Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Clinical trial NCT05217927 · COMPLETED
Trial details
- NCT number
- NCT05217927
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2024-10-22
- Enrollment
- 1415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.